"Endpoint Determination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Establishment of the level of a quantifiable effect indicative of a biologic process. The evaluation is frequently to detect the degree of toxic or therapeutic effect.
| Descriptor ID |
D023381
|
| MeSH Number(s) |
E05.315
|
| Concept/Terms |
Endpoint Determination- Endpoint Determination
- Determination, Endpoint
- Determinations, Endpoint
- Endpoint Determinations
- End Point Determination
- Determinations, End Point
- End Point Determinations
- Point Determinations, End
Endpoint Assay- Endpoint Assay
- Assay, Endpoint
- Assays, Endpoint
- Endpoint Assays
- End Point Assay
- Assay, End Point
- Assays, End Point
- End Point Assays
- Point Assay, End
- Point Assays, End
|
Below are MeSH descriptors whose meaning is more general than "Endpoint Determination".
Below are MeSH descriptors whose meaning is more specific than "Endpoint Determination".
This graph shows the total number of publications written about "Endpoint Determination" by people in this website by year, and whether "Endpoint Determination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 3 | 3 |
| 2004 | 0 | 5 | 5 |
| 2005 | 0 | 2 | 2 |
| 2007 | 2 | 1 | 3 |
| 2009 | 1 | 1 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 2 | 2 |
| 2013 | 0 | 4 | 4 |
| 2014 | 0 | 5 | 5 |
| 2015 | 1 | 2 | 3 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 0 | 2 |
| 2019 | 0 | 2 | 2 |
| 2020 | 3 | 2 | 5 |
| 2021 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 3 | 4 |
| 2025 | 0 | 1 | 1 |
| 2026 | 2 | 3 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Endpoint Determination" by people in Profiles.
-
Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement. Nat Rev Clin Oncol. 2026 Aug; 23(8):619-647.
-
Standardized End Point Definitions for Clinical Trials in Thoracic Aortic Repair: A Consensus Report From the ARCH-Academic Research Consortium. Circulation. 2026 Jun 02; 153(22):1761-1780.
-
Tricuspid Valve Academic Research Consortium-2 (TVARC-2): Trial Design and Endpoints J Am Coll Cardiol. 2026 Apr 21; 87(15):2044-2070.
-
IOlBD evidence-based consensus on the use of artificial intelligence for assessment of endoscopic and histologic endpoints in clinical trials of inflammatory bowel disease. J Crohns Colitis. 2026 Mar 10; 20(3).
-
Machine Learning Models for the Assessment of the Mayo Endoscopic Score in Ulcerative Colitis Trial Endpoints: A Systematic Review. Inflamm Bowel Dis. 2026 Jan 01; 32(1):159-168.
-
Clinical trial design, biomarkers and end points in metabolic and alcohol-related liver disease. Nat Rev Gastroenterol Hepatol. 2025 Dec; 22(12):866-884.
-
Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges. Lancet Respir Med. 2025 Feb; 13(2):177-188.
-
There Is More to Length of Survival Than Survival: Endpoints in Oncology Trials. Clin Cancer Res. 2024 Aug 01; 30(15):3098-3099.
-
Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsies. Clin Trials. 2024 10; 21(5):650-656.
-
Methodological challenges in the development of endpoints for myelofibrosis clinical trials. Lancet Haematol. 2024 May; 11(5):e383-e389.